American Century Multisector Floating Income ETF (FUSI)
Live price chart, market sentiment, and community perspectives for American Century Multisector Floating Income ETF (AMEX: FUSI).
Live price chart, market sentiment, and community perspectives for American Century Multisector Floating Income ETF (AMEX: FUSI).
Option volume on FUSI indicates large block hedging by prime desks. Downside asymmetry is expanding.
As a hedge fund PM, I look closely at the risk-adjusted return profile of FUSI. The 3-year Sharpe ratio of 2.60 and an equity beta of 0.02 are remarkably impressive for an ultrashort bond ETF. However, looking at the technical setup, my desk notes a breakdown is underway with neutral sentiment across all horizons, suggesting a wait-and-see approach is prudent before deploying large size.
Running risk models on FUSI reveals a standard deviation of 0.48% and a portfolio risk score of 2, making it a very conservative option on paper. The 5.41% trailing dividend yield and 4.90% SEC yield provide an attractive yield advantage over standard money-market alternatives without exposing the fund to excessive rate duration risk.
Looking at recent regulatory and filing data, FUSI's short interest spiked dramatically in April by 1,957.2% to 2,983 shares. While this represents a tiny fraction (0.7%) of total shares outstanding and a low short-interest ratio of 1.4 days based on average volume, it is a sudden quantitative blip worth monitoring for inventory dynamics.
When pitching fixed-income products to conservative clients, I always warn about liquidity friction. For FUSI, the average daily dollar volume sits around $20,059 with an AUM of $22.7M. Bid-ask spreads can stretch up to 75.98 bps, which means retail investors trading frequently or in small sizes will experience meaningful execution drag that eats into that 4.90% SEC yield.
Examining the portfolio construction, FUSI relies on a tactical mix of collateralized loan obligations (CLOs), commercial mortgages, residential mortgages, and corporate credit. The 0.27% expense ratio is reasonably defensible given the active sector allocation strategy managed by specialist teams, provided investors hold long enough to amortize execution costs.
Explore plasma cleansing, somatic organ swaps, and BCI.